Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	regulation of SA node cell action potential	ANK2 RYR2	3.90e-05	3	75	2	GO:0098907
GeneOntologyBiologicalProcess	regulation of atrial cardiac muscle cell action potential	ANK2 RYR2	7.79e-05	4	75	2	GO:0098910
GeneOntologyBiologicalProcess	axon guidance	PRTG NELL2 LRP1 LRP2 LAMB1 LAMB3 PTCH1	7.95e-05	285	75	7	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	PRTG NELL2 LRP1 LRP2 LAMB1 LAMB3 PTCH1	8.12e-05	286	75	7	GO:0097485
GeneOntologyBiologicalProcess	positive regulation of lysosomal protein catabolic process	LRP1 LRP2	1.30e-04	5	75	2	GO:1905167
GeneOntologyBiologicalProcess	chemoattraction of axon	LRP1 LRP2	1.30e-04	5	75	2	GO:0061642
GeneOntologyBiologicalProcess	regulation of AV node cell action potential	ANK2 RYR2	1.30e-04	5	75	2	GO:0098904
GeneOntologyCellularComponent	perinuclear region of cytoplasm	NCOR1 UBQLN1 CHERP ANK2 GBP5 SEPTIN14 UBQLN4 LRP1 PPP1R13B LAMB1 PTCH1 DOCK6 SEC23B FBXW7	4.28e-06	934	74	14	GO:0048471
MousePheno	increased chromosomal stability	ZSCAN5DP ZSCAN5A ZSCAN5C	1.81e-06	6	64	3	MP:0010095
Domain	ARM-type_fold	RANBP17 UBQLN1 AP2B1 DOCK8 RTTN HEATR9 ASPM MIF4GD	4.73e-05	339	72	8	IPR016024
Domain	SCAN_BOX	ZSCAN5DP ZSCAN5A ZSCAN5C ZSCAN25	7.36e-05	58	72	4	PS50804
Domain	SCAN	ZSCAN5DP ZSCAN5A ZSCAN5C ZSCAN25	7.36e-05	58	72	4	PF02023
Domain	SCAN_dom	ZSCAN5DP ZSCAN5A ZSCAN5C ZSCAN25	7.36e-05	58	72	4	IPR003309
Domain	Retrov_capsid_C	ZSCAN5DP ZSCAN5A ZSCAN5C ZSCAN25	7.87e-05	59	72	4	IPR008916
Domain	ARM-like	RANBP17 AP2B1 DOCK8 RTTN HEATR9 ASPM ARMH4	8.07e-05	270	72	7	IPR011989
Domain	DUF3398	DOCK8 DOCK6	2.18e-04	6	72	2	PF11878
Domain	Ubiquilin	UBQLN1 UBQLN4	2.18e-04	6	72	2	IPR015496
Domain	DOCK_C/D_N	DOCK8 DOCK6	2.18e-04	6	72	2	IPR021816
Domain	EGF_1	NELL2 LRP1 LRP2 LAMB1 LAMB3 ADAM28	4.49e-04	255	72	6	PS00022
Domain	EGF-like_CS	NELL2 LRP1 LRP2 LAMB1 LAMB3 ADAM28	5.08e-04	261	72	6	IPR013032
Domain	EGF_2	NELL2 LRP1 LRP2 LAMB1 LAMB3 ADAM28	5.50e-04	265	72	6	PS01186
Domain	STI1	UBQLN1 UBQLN4	6.46e-04	10	72	2	SM00727
Domain	STI1_HS-bd	UBQLN1 UBQLN4	6.46e-04	10	72	2	IPR006636
Domain	DOCK_C	DOCK8 DOCK6	7.88e-04	11	72	2	IPR010703
Domain	DHR-1_domain	DOCK8 DOCK6	7.88e-04	11	72	2	IPR027007
Domain	DHR_2	DOCK8 DOCK6	7.88e-04	11	72	2	PS51651
Domain	DHR_1	DOCK8 DOCK6	7.88e-04	11	72	2	PS51650
Domain	DOCK-C2	DOCK8 DOCK6	7.88e-04	11	72	2	PF14429
Domain	DHR-2	DOCK8 DOCK6	7.88e-04	11	72	2	IPR027357
Domain	DHR-2	DOCK8 DOCK6	7.88e-04	11	72	2	PF06920
Domain	DOCK	DOCK8 DOCK6	7.88e-04	11	72	2	IPR026791
Domain	Ldl_recept_b	LRP1 LRP2	1.29e-03	14	72	2	PF00058
Domain	LDLRB	LRP1 LRP2	1.29e-03	14	72	2	PS51120
Domain	SCAN	ZSCAN5A ZSCAN5C ZSCAN25	1.32e-03	56	72	3	SM00431
Domain	PLipase_C_Pinositol-sp_Y	PLCL1 PLCG1	1.49e-03	15	72	2	IPR001711
Domain	EF-hand_like	PLCL1 PLCG1	1.49e-03	15	72	2	PF09279
Domain	PIPLC_Y_DOMAIN	PLCL1 PLCG1	1.49e-03	15	72	2	PS50008
Domain	PI-PLC_fam	PLCL1 PLCG1	1.49e-03	15	72	2	IPR001192
Domain	PLC_EF-hand-like	PLCL1 PLCG1	1.49e-03	15	72	2	IPR015359
Domain	PI-PLC-Y	PLCL1 PLCG1	1.49e-03	15	72	2	PF00387
Domain	PLCYc	PLCL1 PLCG1	1.49e-03	15	72	2	SM00149
Domain	LY	LRP1 LRP2	1.49e-03	15	72	2	SM00135
Domain	LDLR_classB_rpt	LRP1 LRP2	1.49e-03	15	72	2	IPR000033
Domain	-	RANBP17 AP2B1 RTTN HEATR9 ASPM	1.66e-03	222	72	5	1.25.10.10
Domain	Laminin_N	LAMB1 LAMB3	1.70e-03	16	72	2	IPR008211
Domain	LAMININ_NTER	LAMB1 LAMB3	1.70e-03	16	72	2	PS51117
Domain	Laminin_N	LAMB1 LAMB3	1.70e-03	16	72	2	PF00055
Domain	LamNT	LAMB1 LAMB3	1.70e-03	16	72	2	SM00136
Domain	EGF	NELL2 LRP1 LRP2 LAMB1 ADAM28	2.13e-03	235	72	5	SM00181
Domain	PI-PLC-X	PLCL1 PLCG1	2.15e-03	18	72	2	PF00388
Domain	PLCXc	PLCL1 PLCG1	2.15e-03	18	72	2	SM00148
Domain	PIPLC_X_DOMAIN	PLCL1 PLCG1	2.40e-03	19	72	2	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCL1 PLCG1	2.40e-03	19	72	2	IPR000909
Domain	6-PGluconate_DH_C-like	UBQLN1 UBQLN4	2.40e-03	19	72	2	IPR008927
Domain	EGF-like_dom	NELL2 LRP1 LRP2 LAMB1 ADAM28	2.74e-03	249	72	5	IPR000742
Domain	Growth_fac_rcpt_	NELL2 LRP1 LRP2 LAMB1	3.10e-03	156	72	4	IPR009030
Domain	C2H2_Znf_fam	ZSCAN5A REST	3.83e-03	24	72	2	IPR027775
Domain	-	PLCL1 PLCG1	4.15e-03	25	72	2	3.20.20.190
Domain	PLC-like_Pdiesterase_TIM-brl	PLCL1 PLCG1	4.15e-03	25	72	2	IPR017946
Domain	EGF_CA	NELL2 LRP1 LRP2	4.47e-03	86	72	3	PF07645
Domain	cEGF	LRP1 LRP2	4.49e-03	26	72	2	IPR026823
Domain	cEGF	LRP1 LRP2	4.49e-03	26	72	2	PF12662
Domain	EGF_LAM_2	LAMB1 LAMB3	5.95e-03	30	72	2	PS50027
Domain	EGF_LAM_1	LAMB1 LAMB3	5.95e-03	30	72	2	PS01248
Domain	UBA	UBQLN1 UBQLN4	5.95e-03	30	72	2	SM00165
Domain	EGF_Ca-bd_CS	NELL2 LRP1 LRP2	6.25e-03	97	72	3	IPR018097
Domain	EGF_CA	NELL2 LRP1 LRP2	6.61e-03	99	72	3	PS01187
Domain	ASX_HYDROXYL	NELL2 LRP1 LRP2	6.80e-03	100	72	3	PS00010
Pubmed	Zscan5b Deficiency Impairs DNA Damage Response and Causes Chromosomal Aberrations during Mitosis.	ZSCAN5DP ZSCAN5A ZSCAN5C	3.85e-08	4	75	3	31155506
Pubmed	ZSCAN5B and primate-specific paralogs bind RNA polymerase III genes and extra-TFIIIC (ETC) sites to modulate mitotic progression.	ZSCAN5DP ZSCAN5A ZSCAN5C	3.85e-08	4	75	3	27732952
Pubmed	Endocytic Protein Defects in the Neural Crest Cell Lineage and Its Pathway Are Associated with Congenital Heart Defects.	LRP1 LRP2	4.59e-06	2	75	2	34445520
Pubmed	Functional proteomics mapping of a human signaling pathway.	NCOR1 UBQLN1 DOCK8 UBQLN4 LRP1 PPP1R13B VCL RYR2 KNL1	5.15e-06	591	75	9	15231748
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	NCOR1 BBX ETV5 DNAH7 AKAP12 SLC45A4	1.16e-05	233	75	6	37704626
Pubmed	ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.	ASPM FBXW7	1.37e-05	3	75	2	38279565
Pubmed	Human gastric cancer progression and stabilization of ATG2B through RNF5 binding facilitated by autophagy-associated CircDHX8.	ATG2B DHX8	1.37e-05	3	75	2	38866787
Pubmed	Postmortem genetic analysis of sudden unexplained death syndrome under 50 years of age: A next-generation sequencing study.	ANK2 RYR2	1.37e-05	3	75	2	27005929
Pubmed	Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia.	NCOR1 CYP3A43 LRP2	2.71e-05	27	75	3	28167773
Pubmed	Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis.	LRP1 LRP2	2.75e-05	4	75	2	12413896
Pubmed	Functions of sorting nexin 17 domains and recognition motif for P-selectin trafficking.	LRP1 PTCH1	2.75e-05	4	75	2	15769472
Pubmed	Herp enhances ER-associated protein degradation by recruiting ubiquilins.	UBQLN1 UBQLN4	2.75e-05	4	75	2	18307982
Pubmed	Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1.	LRP1 LRP2	2.75e-05	4	75	2	7775583
Pubmed	Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.	LRP1 LRP2	2.75e-05	4	75	2	11421580
Pubmed	Genetic link between renal birth defects and congenital heart disease.	FREM2 AP2B1 LRP2	3.04e-05	28	75	3	27002738
Pubmed	Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development.	MYOF AP2B1 PTCH1	3.04e-05	28	75	3	26884322
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	FREM2 LAMB1 LAMB3	3.38e-05	29	75	3	22613833
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NCOR1 GAPVD1 UBQLN4 ATG2B LRP1 LRP2 KNL1	3.39e-05	418	75	7	34709266
Pubmed	NLRP14 deficiency causes female infertility with oocyte maturation defects and early embryonic arrest by impairing cytoplasmic UHRF1 abundance.	ZSCAN5DP ZSCAN5A ZSCAN5C	4.57e-05	32	75	3	38060382
Pubmed	ApoER2 is endocytosed by a clathrin-mediated process involving the adaptor protein Dab2 independent of its Rafts' association.	LRP1 LRP2	4.57e-05	5	75	2	16101684
Pubmed	Interaction of the apolipoprotein E receptors low density lipoprotein receptor-related protein and sorLA/LR11.	LRP1 LRP2	4.57e-05	5	75	2	19047013
Pubmed	NELL2-mediated lumicrine signaling through OVCH2 is required for male fertility.	NELL2 ADAM28	4.57e-05	5	75	2	32499443
Pubmed	Interaction of coagulation factor VIII with members of the low-density lipoprotein receptor family follows common mechanism and involves consensus residues within the A2 binding site 484-509.	LRP1 LRP2	4.57e-05	5	75	2	18685438
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	NCOR1 NELL2 UBQLN1 UBQLN4 MIF4GD LRP2 LAMB1 KAT6B	5.02e-05	608	75	8	16713569
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	RANBP17 EPC1 ASPM SEC23B FBXW7	5.28e-05	186	75	5	33637726
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	NCOR1 BBX ZSCAN5DP ZSCAN5A ZSCAN5C ETV5 PLCG1 REST KAT6B	6.02e-05	808	75	9	20412781
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	FREM2 AP2B1 LRP1 LRP2	6.69e-05	100	75	4	25807483
Pubmed	Expression and localization of laminin-5 subunits in the mouse incisor.	LAMB1 LAMB3	6.84e-05	6	75	2	9506922
Pubmed	RTL8 promotes nuclear localization of UBQLN2 to subnuclear compartments associated with protein quality control.	UBQLN1 UBQLN4	6.84e-05	6	75	2	35247097
Pubmed	Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein.	LRP1 LRP2	6.84e-05	6	75	2	9837937
Pubmed	Expansion of the renal capsular stroma, ureteric bud branching defects and cryptorchidism in mice with Wilms tumor 1 gene deletion in the stromal compartment of the developing kidney.	ETV5 PTCH1 AKAP12	7.70e-05	38	75	3	32715478
Pubmed	Blood-Brain Barrier: From Physiology to Disease and Back.	LRP1 LRP2 SLC38A3 VCL	8.08e-05	105	75	4	30280653
Pubmed	Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling.	IVNS1ABP NCOR1 MAEA PLCG1 AKAP12 VCL	8.37e-05	332	75	6	29053956
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NELL2 UBQLN1 ANK2 AP2B1 UBQLN4 ADGRB3 LRP1 LRP2 LAMB1 MAGI3 PLCG1	9.40e-05	1285	75	11	35914814
Pubmed	Megalin mediates the influence of sonic hedgehog on oligodendrocyte precursor cell migration and proliferation during development.	LRP2 PTCH1	9.57e-05	7	75	2	22354480
Pubmed	Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor.	LAMB1 LAMB3	9.57e-05	7	75	2	9004048
Pubmed	Defects and rescue of the minor salivary glands in Eda pathway mutants.	ETV5 PTCH1	9.57e-05	7	75	2	20969842
Pubmed	The PX-domain protein SNX17 interacts with members of the LDL receptor family and modulates endocytosis of the LDL receptor.	LRP1 LRP2	9.57e-05	7	75	2	12169628
Pubmed	Structure of hRpn10 Bound to UBQLN2 UBL Illustrates Basis for Complementarity between Shuttle Factors and Substrates at the Proteasome.	UBQLN1 UBQLN4	9.57e-05	7	75	2	30664872
Pubmed	ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.	YEATS4 EPC1 KAT6B	1.04e-04	42	75	3	16387653
Pubmed	Expression and localization of laminin-5 subunits during mouse tooth development.	LAMB1 LAMB3	1.27e-04	8	75	2	9489770
Pubmed	Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery.	UBQLN1 UBQLN4	1.27e-04	8	75	2	23459205
Pubmed	Mouse kalinin B1 (laminin beta 3 chain): cloning and tissue distribution.	LAMB1 LAMB3	1.27e-04	8	75	2	7898049
Pubmed	Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis.	LAMB1 LAMB3	1.27e-04	8	75	2	23529140
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	MYOF IQCA1L ZSCAN5DP ZSCAN5A ZSCAN5C ASPM	1.36e-04	363	75	6	14691545
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	NELL2 YEATS4 RTL9 EPC1 ASPM LRP1 LRP2 LAMB1 KAT6B KNL1	1.39e-04	1116	75	10	31753913
Pubmed	LDL receptor-related protein as a component of the midkine receptor.	LRP1 LRP2	1.64e-04	9	75	2	10772929
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GAPVD1 CHERP ANK2 AP2B1 ATG2B PLCG1 AKAP12 VCL KNL1	1.80e-04	934	75	9	33916271
Pubmed	Establishment and Dysfunction of the Blood-Brain Barrier.	LRP1 LRP2 SLC38A3	1.97e-04	52	75	3	26590417
Pubmed	Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons.	LAMB1 LAMB3	2.04e-04	10	75	2	9034910
Pubmed	A dosage-dependent role for Spry2 in growth and patterning during palate development.	ETV5 PTCH1	2.04e-04	10	75	2	17693063
Pubmed	A forward genetic screen in mice identifies mutants with abnormal cortical patterning.	LRP2 DRC3	2.49e-04	11	75	2	23968836
Pubmed	The highly conserved and multifunctional NuA4 HAT complex.	YEATS4 EPC1	2.49e-04	11	75	2	15196461
Pubmed	Fuz mutant mice reveal shared mechanisms between ciliopathies and FGF-related syndromes.	ETV5 PTCH1	2.49e-04	11	75	2	23806618
Pubmed	The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation.	NCOR1 REST	2.49e-04	11	75	2	17468742
Pubmed	LRP2 mediates folate uptake in the developing neural tube.	LRP1 LRP2	2.49e-04	11	75	2	24639464
Pubmed	Regional differences in the expression of laminin isoforms during mouse neural tube development.	LAMB1 LAMB3	2.49e-04	11	75	2	21524702
Pubmed	Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.	LAMB1 LAMB3	2.49e-04	11	75	2	23472759
Pubmed	ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation.	ZSCAN5DP ZSCAN5A ZSCAN5C	2.73e-04	58	75	3	31598710
Pubmed	NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function.	REST RYR2	2.99e-04	12	75	2	14633990
Pubmed	Control of chromosome stability by the beta-TrCP-REST-Mad2 axis.	REST FBXW7	2.99e-04	12	75	2	18354482
Pubmed	Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice.	LAMB1 LAMB3	2.99e-04	12	75	2	8918877
Pubmed	Nubp2 is required for cranial neural crest survival in the mouse.	ETV5 PTCH1	2.99e-04	12	75	2	31733190
Pubmed	Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice.	LAMB1 LAMB3	2.99e-04	12	75	2	9396756
Pubmed	Excess NF-κB induces ectopic odontogenesis in embryonic incisor epithelium.	ETV5 PTCH1	3.52e-04	13	75	2	25376721
Pubmed	Sequence diversity and haplotype structure at the human CYP3A cluster.	CYP3A43 ZSCAN25	3.52e-04	13	75	2	16314882
Pubmed	UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome.	UBQLN1 UBQLN4	3.52e-04	13	75	2	27477512
Pubmed	Preaxial polydactyly: interactions among ETV, TWIST1 and HAND2 control anterior-posterior patterning of the limb.	ETV5 PTCH1	4.11e-04	14	75	2	20826535
Pubmed	Conditional deletion of NRSF in forebrain neurons accelerates epileptogenesis in the kindling model.	PLCG1 REST	4.11e-04	14	75	2	21339379
Pubmed	Stage-specific association of apolipoprotein A-I and E in developing mouse retina.	LRP1 LRP2	4.11e-04	14	75	2	17389516
Pubmed	Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1.	LRP1 LRP2	4.11e-04	14	75	2	15082773
Pubmed	Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.	DOCK8 DOCK6	4.11e-04	14	75	2	12432077
Pubmed	Basement membrane composition in the early mouse embryo day 7.	LAMB1 LAMB3	4.73e-04	15	75	2	15895400
Pubmed	Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice.	GBP5 PLCG1	4.73e-04	15	75	2	17114464
Pubmed	Localization of basement membrane-associated protein isoforms during development of the ocular surface of mouse eye.	LAMB1 LAMB3	4.73e-04	15	75	2	9264260
Pubmed	LRP2 is an auxiliary SHH receptor required to condition the forebrain ventral midline for inductive signals.	LRP2 PTCH1	4.73e-04	15	75	2	22340494
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	NCOR1 GAPVD1 LRP2 PPP1R13B MAGI3 FHIP2A DNAH7 VCL	5.02e-04	853	75	8	28718761
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	IVNS1ABP GAPVD1 YEATS4 BBX AP2B1 MAEA RTL9 ATG2B AKAP12 VCL	5.31e-04	1321	75	10	27173435
Pubmed	Hand1 phosphoregulation within the distal arch neural crest is essential for craniofacial morphogenesis.	ETV5 PTCH1	5.40e-04	16	75	2	25053435
Pubmed	Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling.	LAMB1 LAMB3	5.40e-04	16	75	2	17601529
Pubmed	Late gestational lung hypoplasia in a mouse model of the Smith-Lemli-Opitz syndrome.	LRP2 PTCH1	5.40e-04	16	75	2	15005800
Pubmed	Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development.	LAMB3 PTCH1	5.40e-04	16	75	2	12533516
Pubmed	Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.	ETV5 VCL	5.40e-04	16	75	2	19004856
Pubmed	Primary Autosomal Recessive Microcephalies and Seckel Syndrome Spectrum Disorders – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	ASPM KNL1	5.40e-04	16	75	2	20301772
Pubmed	The Genetic Basis of Baculum Size and Shape Variation in Mice.	ASPM PLCG1	5.40e-04	16	75	2	26935419
Pubmed	A proteome-scale map of the SARS-CoV-2-human contactome.	UBQLN1 LCN15 MIF4GD DHX8	5.46e-04	173	75	4	36217029
Pubmed	LRP2/megalin is required for patterning of the ventral telencephalon.	LRP2 PTCH1	6.11e-04	17	75	2	15623804
Pubmed	TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts.	LAMB1 LAMB3	6.87e-04	18	75	2	23041440
Pubmed	Gata6-Dependent GLI3 Repressor Function is Essential in Anterior Limb Progenitor Cells for Proper Limb Development.	ETV5 PTCH1	6.87e-04	18	75	2	27352137
Pubmed	Tissue-specific roles of FGF signaling in external genitalia development.	ETV5 PTCH1	6.87e-04	18	75	2	25820239
Pubmed	A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1.	FREM2 LAMB1	6.87e-04	18	75	2	14730302
Pubmed	Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53.	LAMB1 LAMB3	6.87e-04	18	75	2	11311202
Pubmed	Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction.	LRP1 LRP2	6.87e-04	18	75	2	10827173
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	IVNS1ABP UBQLN1 ETV5 LAMB3 FHIP2A C2orf78 ADAM28	7.00e-04	686	75	7	29987050
Pubmed	Specific 3-O-sulfated heparan sulfate domains regulate salivary gland basement membrane metabolism and epithelial differentiation.	ETV5 LAMB1 LAMB3	7.28e-04	81	75	3	39217171
Pubmed	The mammalian YL1 protein is a shared subunit of the TRRAP/TIP60 histone acetyltransferase and SRCAP complexes.	YEATS4 EPC1	7.66e-04	19	75	2	15647280
Pubmed	SP8 regulates signaling centers during craniofacial development.	ETV5 PTCH1	7.66e-04	19	75	2	23872235
Pubmed	The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.	VCL FBXW7	7.66e-04	19	75	2	22405651
Pubmed	Tagging genes with cassette-exchange sites.	RANBP17 NCOR1 CHERP REST KAT6B	8.00e-04	335	75	5	15741177
Pubmed	An improved method for the synthesis of cellulose membrane-bound peptides with free C termini is useful for PDZ domain binding studies.	ADGRB3 LAMB1 NMU	8.10e-04	84	75	3	15123239
Interaction	SLC45A4 interactions	UBQLN1 UBQLN4 SLC45A4	7.37e-06	11	73	3	int:SLC45A4
Cytoband	19q13.43	ZSCAN5DP ZSCAN5A ZSCAN5C	4.02e-04	87	75	3	19q13.43
Cytoband	10q24	MYOF PDE6C	1.51e-03	35	75	2	10q24
Cytoband	10q22.2	KAT6B VCL	2.07e-03	41	75	2	10q22.2
GeneFamily	Ubiquilin family	UBQLN1 UBQLN4	6.87e-05	5	48	2	783
GeneFamily	Laminin subunits	LAMB1 LAMB3	4.48e-04	12	48	2	626
GeneFamily	Low density lipoprotein receptors	LRP1 LRP2	5.28e-04	13	48	2	634
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCL1 PLCG1	1.15e-03	19	48	2	832
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	NCOR1 PPP1R13B PLCL1 KNL1	1.34e-03	181	48	4	694
CoexpressionAtlas	MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05	PRTG NELL2 BBX ANK2 RTTN LRP2 ETV5 MAGI3 RENBP PLCG1 ZSCAN25 PTCH1 KAT6B DOCK6 AKAP12 FBXW7	2.65e-06	1245	71	16	PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500	MYOF ASPM LRP1 LBH PTCH1 ARMH4	1.90e-05	165	71	6	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	MYOF ASPM LRP1 LBH ETV5 PPP1R13B LAMB1 REST PTCH1 KNL1 ARMH4	6.09e-05	793	71	11	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 ADGRB3 LRP1 LAMB1 PTCH1 RYR2	3.22e-08	189	75	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 AKAP12 RYR2	4.28e-08	197	75	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 PTCH1 RYR2	4.58e-08	199	75	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 PTCH1 AKAP12	4.58e-08	199	75	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 PTCH1 AKAP12	4.74e-08	200	75	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADGRB3 LRP1 LBH LAMB1 AKAP12 RYR2	4.74e-08	200	75	7	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LAMB1 PTCH1 AKAP12 RYR2	4.74e-08	200	75	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADGRB3 LRP1 LBH LAMB1 AKAP12 RYR2	4.74e-08	200	75	7	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NELL2 LRP1 LBH ETV5 GRIK3 ARMH4	7.79e-07	188	75	6	a244fcd092d5bd544e503366b1439b0fbc1ee00e
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NELL2 LRP1 LBH ETV5 GRIK3 ARMH4	7.79e-07	188	75	6	c8530c9ff98666c64a94683261af4288cb790a7e
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	ANK2 PPP1R13B CHST9 PLCL1 VCL RYR2	8.03e-07	189	75	6	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 LRP1 LBH LAMB1 RYR2	8.80e-07	192	75	6	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	FREM2 PRTG LRP2 ETV5 PPP1R13B MAGI3	8.80e-07	192	75	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RANBP17 FREM2 PPP1R13B MAGI3 PLCL1 NMU	8.80e-07	192	75	6	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 LRP1 LBH LAMB1 RYR2	8.80e-07	192	75	6	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 ANK2 LRP2 LAMB3 CHST9 DNAH7	8.80e-07	192	75	6	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 LRP1 LBH LAMB1 RYR2	8.80e-07	192	75	6	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 LRP1 LBH LAMB1 RYR2	9.35e-07	194	75	6	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FREM2 NELL2 ETV5 PPP1R13B LAMB3 MAGI3	1.05e-06	198	75	6	1851b7f4198b42c21c934e2fbda39dbd65e2625c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ANK2 ADGRB3 LBH LAMB1 PTCH1 RYR2	1.05e-06	198	75	6	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 AKAP12	1.08e-06	199	75	6	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 AKAP12	1.08e-06	199	75	6	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 AKAP12	1.08e-06	199	75	6	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 AKAP12	1.12e-06	200	75	6	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 AKAP12	1.12e-06	200	75	6	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADGRB3 LRP1 LAMB1 AKAP12 RYR2	1.12e-06	200	75	6	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRB3 LRP1 LBH LAMB1 AKAP12 RYR2	1.12e-06	200	75	6	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYOF LRP1 LAMB1 PTCH1 VCL RYR2	1.12e-06	200	75	6	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 AKAP12	1.12e-06	200	75	6	3bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 AKAP12	1.12e-06	200	75	6	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADGRB3 LRP1 LAMB1 AKAP12 RYR2	1.12e-06	200	75	6	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LBH LAMB1 AKAP12	1.12e-06	200	75	6	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ANK2 LRP1 LBH LAMB1 PTCH1 AKAP12	1.12e-06	200	75	6	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IVNS1ABP FREM2 LRP2 SLC13A5 SLC45A4	5.69e-06	151	75	5	f4f7156b2c0cfc78fd1841e07c9915d97ced561f
ToppCell	356C-Lymphocytic-ILC-ILC-3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HEATR9 ETV5 CHST9 KAT6B ARMH4	8.25e-06	163	75	5	2dbdcbc4c187aad3db837d191cc78662a75dd0b5
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GBP5 LBH PLCL1 PLCG1 FHIP2A	8.76e-06	165	75	5	dbe231d00843cae917efd1abea6079ace3b45cdf
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GBP5 LBH PLCL1 PLCG1 FHIP2A	8.76e-06	165	75	5	9ccce713d4122054bf4bef4a7126d90cf9141b84
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	BBX CHERP EPC1 ZSCAN25 SLC45A4	9.02e-06	166	75	5	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ASPM PPP1R13B RTN4IP1 SLC38A3 KNL1	1.20e-05	176	75	5	8385435074cc5235b7af7424974f609388fc2cff
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	RANBP17 FREM2 PRTG LRP2 MAGI3	1.48e-05	184	75	5	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FREM2 PRTG PPP1R13B MAGI3 PLCL1	1.48e-05	184	75	5	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FREM2 NELL2 ETV5 LAMB3 MAGI3	1.52e-05	185	75	5	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ANK2 PPP1R13B CHST9 PLCL1 RYR2	1.69e-05	189	75	5	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	LBH LAMB1 PTCH1 AKAP12 VCL	1.69e-05	189	75	5	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RANBP17 FREM2 ETV5 PPP1R13B MAGI3	1.73e-05	190	75	5	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ANK2 PPP1R13B CHST9 PLCL1 RYR2	1.73e-05	190	75	5	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	LBH LAMB1 PTCH1 AKAP12 VCL	1.73e-05	190	75	5	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 LRP2 ETV5 LAMB3 CHST9	1.73e-05	190	75	5	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 LRP1 LAMB1 RYR2	1.73e-05	190	75	5	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NELL2 LRP1 ETV5 GRIK3 ARMH4	1.73e-05	190	75	5	9b825b2586c7b173ff27fcf2abc5860faf50984a
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ANK2 ADGRB3 LAMB1 AKAP12 RYR2	1.73e-05	190	75	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NELL2 LRP1 ETV5 GRIK3 ARMH4	1.73e-05	190	75	5	d146af1926474328a7c822bc140c4dda66e1bbfb
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 ADGRB3 LRP1 LAMB1 RYR2	1.77e-05	191	75	5	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 LRP2 LAMB3 CHST9 DNAH7	1.77e-05	191	75	5	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FREM2 ASPM CHST9 KNL1 NMU	1.77e-05	191	75	5	39220f4a345e328f7fa4fd462a0abeea821b3e02
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FREM2 PRTG ETV5 PPP1R13B MAGI3	1.77e-05	191	75	5	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RANBP17 FREM2 PPP1R13B MAGI3 NMU	1.77e-05	191	75	5	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	RANBP17 FREM2 PPP1R13B MAGI3 NMU	1.77e-05	191	75	5	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 ADGRB3 LRP1 LBH LAMB1	1.82e-05	192	75	5	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 ASPM LRP2 LAMB3 NMU	1.82e-05	192	75	5	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 LRP1 LAMB1 RYR2	1.82e-05	192	75	5	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 LRP2 ETV5 LAMB3 CHST9	1.82e-05	192	75	5	b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 LRP1 LAMB1 RYR2	1.82e-05	192	75	5	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RANBP17 FREM2 ETV5 PPP1R13B MAGI3	1.82e-05	192	75	5	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 LRP1 LAMB1 RYR2	1.82e-05	192	75	5	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FREM2 PRTG LRP2 ETV5 MAGI3	1.87e-05	193	75	5	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FREM2 PRTG LRP2 ETV5 MAGI3	1.87e-05	193	75	5	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	LRP1 LBH LAMB1 PTCH1 AKAP12	1.91e-05	194	75	5	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IVNS1ABP FREM2 LAMB1 PLCL1 DNAH7	1.91e-05	194	75	5	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRB3 LBH LAMB1 PTCH1 RYR2	1.91e-05	194	75	5	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 LRP2 LAMB3 CHST9 DNAH7	1.91e-05	194	75	5	6b286992d4bb56013c0ea5a7601d3476d806175a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF ANK2 ADGRB3 LRP1 LAMB1	1.91e-05	194	75	5	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 LRP2 LAMB3 CHST9 DNAH7	1.91e-05	194	75	5	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADGRB3 LRP1 LBH LAMB1 RYR2	1.96e-05	195	75	5	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADGRB3 LRP1 LBH LAMB1 RYR2	1.96e-05	195	75	5	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FREM2 NELL2 ETV5 PPP1R13B LAMB3	1.96e-05	195	75	5	0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542
ToppCell	wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RANBP17 FREM2 LAMB3 MAGI3 NMU	2.01e-05	196	75	5	e24a7aaf41793abba66c1189d933ca05b14c1af9
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LRP1 LAMB1 GRIK3 PTCH1 AKAP12	2.06e-05	197	75	5	2cb1f557ce1400398975de94638126b4522567f3
ToppCell	mild-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GBP5 EPC1 LBH PLCL1 FHIP2A	2.06e-05	197	75	5	39800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANK2 ADGRB3 CHST9 GRIK3 AKAP12	2.06e-05	197	75	5	b2f4d7c301c0b24003374923b31d6d058e40b213
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYOF LRP1 LBH LAMB1 AKAP12	2.11e-05	198	75	5	0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADGRB3 LRP1 LBH LAMB1 RYR2	2.11e-05	198	75	5	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	ANK2 ADGRB3 LAMB1 AKAP12 RYR2	2.11e-05	198	75	5	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FREM2 PRTG LRP2 ETV5 PPP1R13B	2.11e-05	198	75	5	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ANK2 ADGRB3 LBH LAMB1 RYR2	2.11e-05	198	75	5	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FREM2 NELL2 PPP1R13B LAMB3 MAGI3	2.11e-05	198	75	5	c477405b093f4e5374e57bcacf1fb204a0f7eb3b
ToppCell	severe-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GBP5 EPC1 LBH PLCL1 FHIP2A	2.11e-05	198	75	5	4935b40fc848037a06055f30d90bde940b9d5321
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RANBP17 FREM2 LRP2 PPP1R13B MAGI3	2.16e-05	199	75	5	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	ADGRB3 LBH LAMB1 AKAP12 RYR2	2.16e-05	199	75	5	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LAMB1 AKAP12	2.16e-05	199	75	5	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	distal-1-Epithelial-Proliferating_Basal\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	YEATS4 ASPM LAMB3 KNL1 NMU	2.16e-05	199	75	5	93450257180d918c310bca7b5defc74390c48091
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRP1 LAMB1 PTCH1 ADAM28 AKAP12	2.16e-05	199	75	5	6139687a3a5025cb98da4dba0183f95fcae3dc61
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMB1 PTCH1 ADAM28 AKAP12 VCL	2.16e-05	199	75	5	3d8c76e3d05acf72a35ca755b51579fc3ae63562
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYOF ANK2 LRP1 LAMB1 RYR2	2.16e-05	199	75	5	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	LRP1 LBH LAMB1 AKAP12 RYR2	2.16e-05	199	75	5	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	LRP1 LBH LAMB1 AKAP12 RYR2	2.16e-05	199	75	5	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ANK2 LAMB1 PTCH1 ADAM28 AKAP12	2.16e-05	199	75	5	615f20bf136dfef53b072667cf0e4df6a1017e05
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYOF LRP1 LBH LAMB1 AKAP12	2.21e-05	200	75	5	ab4fda0cc95cb8f80ea9f28745013f3248def820
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	LRP1 LBH LAMB1 PTCH1 AKAP12	2.21e-05	200	75	5	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	distal-Epithelial-Proliferating_Basal\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	YEATS4 ASPM LAMB3 KNL1 NMU	2.21e-05	200	75	5	25cc494ef831511840d8c02ec1bd086635cc7edd
Drug	Foliosidine [2520-38-9]; Up 200; 13uM; HL60; HT_HG-U133A	RANBP17 MYOF LRP2 LBH DOCK6 ADAM28 FBXW7	3.51e-06	199	73	7	2201_UP
Disease	amyotrophic lateral sclerosis type 15 (implicated_via_orthology)	UBQLN1 UBQLN4	1.81e-05	3	73	2	DOID:0060206 (implicated_via_orthology)
Disease	Primary microcephaly	RTTN ASPM KNL1	2.16e-05	22	73	3	C0431350
Disease	worry measurement	GAPVD1 BBX PLCL1 PTCH1 SLC38A3	4.09e-05	154	73	5	EFO_0009589
Disease	underweight body mass index status	ANK2 ADGRB3	2.15e-04	9	73	2	EFO_0005936
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	ANK2 RYR2	2.68e-04	10	73	2	C1631597
Disease	urokinase-type plasminogen activator measurement	CHST9 VCL	3.27e-04	11	73	2	EFO_0010803
Disease	Colorectal Carcinoma	ANK2 ZSCAN5A LRP1 LRP2 LAMB3 GRIK3 AKAP12 FBXW7	3.40e-04	702	73	8	C0009402
Disease	frontotemporal dementia (implicated_via_orthology)	UBQLN1 UBQLN4	3.92e-04	12	73	2	DOID:9255 (implicated_via_orthology)
Disease	methionine sulfone measurement	SLC7A9 CYP3A43	3.92e-04	12	73	2	EFO_0800072
Disease	neurodegenerative disease (implicated_via_orthology)	UBQLN1 UBQLN4 GRIK3 PTCH1	4.68e-04	145	73	4	DOID:1289 (implicated_via_orthology)
Disease	serum metabolite measurement	SLC7A9 CYP3A43 LAMB1 PLCL1 ZSCAN25 DOCK6 C2orf78 SLC45A4 ARMH4	5.28e-04	945	73	9	EFO_0005653
Disease	risk-taking behaviour	PRTG GAPVD1 UBQLN4 PPP1R13B REST PTCH1 RYR2 ARMH4	5.94e-04	764	73	8	EFO_0008579
Disease	Autosomal recessive primary microcephaly	ASPM KNL1	6.21e-04	15	73	2	cv:C3711387
Disease	primary autosomal recessive microcephaly (is_implicated_in)	ASPM KNL1	7.08e-04	16	73	2	DOID:0070296 (is_implicated_in)
Disease	urate measurement, bone density	RANBP17 GBP5 ADGRB3 MAGI3 KAT6B SLC38A3 AKAP12	8.51e-04	619	73	7	EFO_0003923, EFO_0004531
Disease	metabolonic lactone sulfate measurement	CYP3A43 ZSCAN25	1.00e-03	19	73	2	EFO_0800659
Disease	diastolic blood pressure, systolic blood pressure	GAPVD1 ANK2 LRP1 DNAH7 RYR2 SLC45A4 FBXW7	1.34e-03	670	73	7	EFO_0006335, EFO_0006336
Disease	Autosomal Recessive Primary Microcephaly	ASPM KNL1	1.35e-03	22	73	2	C3711387
Disease	neurotic disorder	BBX GRIK3 PTCH1	2.03e-03	101	73	3	EFO_0004257
Disease	neutrophil count	BBX DOCK8 UBQLN4 LBH MAGI3 PLCL1 REST DOCK6 AKAP12 SLC45A4	2.08e-03	1382	73	10	EFO_0004833
Disease	Pigmented Basal Cell Carcinoma	PTCH1 FBXW7	2.19e-03	28	73	2	C1368275
Disease	Child Development Disorders, Specific	DOCK8 LRP2	2.35e-03	29	73	2	C0085997
Disease	Child Development Deviations	DOCK8 LRP2	2.35e-03	29	73	2	C0085996
Disease	Carcinoma, Basal Cell	PTCH1 FBXW7	2.35e-03	29	73	2	C4721806

Protein segments in the cluster

Peptide	Gene	Start	Entry
EIMSEVMAQRQPMKP	EPC1	281	Q9H2F5
MDKNVPQLPQDEMIV	BDP1	2456	A6H8Y1
LGPVMKMEPLNNLQV	AP2B1	791	P63010
EMPQLNFGMADPTQM	BBX	191	Q8WY36
AHQPEMVMVLKEVQP	C2orf78	241	A6NCI8
MVMVLKEVQPTNVLP	C2orf78	246	A6NCI8
PQMVKAVQPQEMSQM	ADAM28	716	Q9UKQ2
MNPPVMDQFNMNLEQ	ADGRB3	1351	O60242
GVKSQEMVMEQAIPP	AKAP12	1146	Q02952
PQLVVSEDPMMMSAV	ARMH4	66	Q86TY3
MEEITNPLQAIQMVM	ASPM	3456	Q8IZT6
MMPMILTVFLSNNEQ	PPP1R13B	1	Q96KQ4
VMFENEQMVMPGDPV	ATG2B	906	Q96BY7
EQMVMPGDPVEMTEF	ATG2B	911	Q96BY7
PDVLQQMMSVLMNTI	RANBP17	976	Q9H2T7
LQNMETSPMMDVPSV	KAT6B	1641	Q8WYB5
EEIMVQGMPQEPVNI	ANK2	3916	Q01484
AEPMAVPMMLLNLVE	RENBP	186	P51606
MQVVQKEPVQMELSP	REST	721	Q13127
VVQKEPVQMELSPPM	REST	771	Q13127
KISGDVMNENNPPMM	MAEA	341	Q7L5Y9
MNPQDFKPGAMVLEQ	MAGI3	526	Q5TCQ9
LCFMIMGMLPKPQEQ	NMU	81	P48645
FKGIMQDVQLLVMPQ	NELL2	201	Q99435
MQQDELIEKPMSPMQ	IVNS1ABP	341	Q9Y6Y0
KVPDEHMIPIENLMN	LRP1	546	Q07954
VMMNTQPMEEIGLSP	LBH	21	Q53QV2
IVIIPTNDEQPEMFM	FREM2	1181	Q5SZK8
TPGMMSENEVLNMQL	GAPVD1	526	Q14C86
LVGPEIQVMQMMSPD	DSG4	996	Q86SJ6
IQVMQMMSPDLPIGQ	DSG4	1001	Q86SJ6
LERTVLQQQPIPMMD	PDE6C	751	P51160
NEVLKMEMPSTPQQL	LAMB1	1526	P07942
AAPTPEKEMMLQNLM	KNL1	536	Q8NG31
QMGQKVQLPMETLQE	GBP5	336	Q96PP8
LQMPKMMPENQYPSE	ETV5	201	P41161
MMVMLPQSDACNPES	LCN15	166	Q6UWW0
VMEMGKQPIIFENPM	LRP2	4511	P98164
AVGNEESLMPMIMPN	PRTG	1011	Q2VWP7
EQDPPDAKMLQMVLQ	DOCK6	1921	Q96HP0
VAINQEPPDAKMLQM	DOCK8	1961	Q8NF50
EGQQPMLVIMDPDMI	CYP3A43	76	Q9HB55
QLQMPQMEAEVKATP	CHERP	341	Q8IWX8
MHLQMLMEVVPPEED	SLC7A9	471	P82251
MSGEIIQMSPQMNLI	DNAH7	1716	Q8WXX0
IQMSPQMNLIFEPMD	DNAH7	1721	Q8WXX0
EPTQVKHMMQVIEPQ	FBXW7	261	Q969H0
VQLMQPKAMPVEVLG	KHDC3L	11	Q587J8
LQEVMMEFQGPMPAG	LAMB3	116	Q13751
MNQPCNSMEPRVMDD	DRC3	1	Q9H069
FIGVMEPQLMQTSEM	FHIP2A	391	Q5W0V3
LLEDFILNMQMPQVP	GPR139	86	Q6DWJ6
ILNMQMPQVPDKIIE	GPR139	91	Q6DWJ6
QPPMMVKTDAVINMH	GRIK3	881	Q13003
AMMVPIVEAILQQME	SLC13A5	146	Q86YT5
MSNPVPMPEVQEKFQ	RYR2	4406	Q92736
MDAPPMETLITAMEQ	DHX8	946	Q14562
RVNNMPMMALVNPVY	MIF4GD	116	A9UHW6
QNMMMPIIHYPNEVI	RTN4IP1	61	Q8WWV3
ILMQDMNPGVMSTQP	RTL9	206	Q8NET4
MPLENTTVQQMVFML	RTTN	2021	Q86VV8
MEAPLQTEMVELVPN	SLC38A3	1	Q99624
MAERTMAMPTQIPAD	SEPTIN14	1	Q6ZU15
RMEMEFIGMLPSPNQ	IQCA1L	231	A6NCM1
QMRQLSVIPPMMFDA	NCOR1	396	O75376
AMFNPQLMIQTPKEE	PTCH1	151	Q13635
QDMLGLTKPAMPMQQ	SEC23B	201	Q15437
MQPSEMVMNPKQVFL	CHST9	1	Q7L1S5
MKMAPQNADPESMQV	SLC45A4	1	Q5BKX6
IVAMNFQTPGPMMDL	PLCL1	666	Q15111
MEQFMISMPQELQVL	ZSCAN5DP	86	P0CG00
SNPEMMVQIMENPFV	UBQLN1	181	Q9UMX0
MVQIMENPFVQSMLS	UBQLN1	186	Q9UMX0
MLKEHPEMAEAPQQQ	ZSCAN25	1	Q6NSZ9
PTMMNLVEAQLMNPD	HEATR9	401	A2RTY3
PEQKAGEVINQPMMM	VCL	886	P18206
QFMISMPQELQVLVM	ZSCAN5A	91	Q9BUG6
MPQELQVLVMMNGVQ	ZSCAN5A	96	Q9BUG6
QTPDKPMQMNQALFM	PLCG1	1041	P19174
EMIFQDPTAMMQQLL	YEATS4	141	O95619
LSQIMENPLVQDMMS	UBQLN4	196	Q9NRR5
ENPLVQDMMSNPDLM	UBQLN4	201	Q9NRR5
QFMISMPQELQVLVM	ZSCAN5C	91	A6NGD5
MPQELQVLVMMNGVQ	ZSCAN5C	96	A6NGD5
LMQLTEEPQNSMPDI	MYOF	761	Q9NZM1